Escolar Documentos
Profissional Documentos
Cultura Documentos
br
FASEOLAMINA
DOSES E USOS: Uso oral. Doses usuais de 300 a 900 mg ao dia, divididas em 2 a 3
tomadas, às refeições.
INTERAÇÕES: A Faseolamina pode ter seu efeito potencializado com a associação de:
picolinato de cromo, vanádio, gymena, garcínia, L-carnitina.
Alcântara - Rua Yolanda Saad Abuzaid, 150, loja s 118/119. Telefone (21) 2601-1130
Ce ntro / Zé Garoto Rua Coronel Serrado, 1630, loja s 102/103. Telefone (21) 2605-1349
-
vendas@farmacam.com.br Facebook.com.br/farmacam
whatsapp (21) 98493-7033 Instagram.com.br/farmacam
www.farmacam.com.br
REFERÊNCIAS
BATISTUZZO, J.A.O., ITAYA, M., ETO,Y. Formulário Médico Farmacêu tico. 3.ed.
São Paulo: P harmabooks. 2006.
Ma rshall JJ Alpha-amylase inhibitors from pl ants. Am Chem Soc Symp Ser. 1975;15: 244-
.
266.
Vinson JA, Shuta DM. In vivo effectiveness of a starch abso rption blocker in a double -
bli nd pla cebocontrolled stud y with normal human subj ects. Unpublished data, University of
Scranton, September 6, 2001.
Vinson, JA, Shuta DM. In vivo effectiven ess of a sta rch a bsorption bloc ker in a double-
bli nd, pla cebocontrolled study with normal college age subje cts. Unpublish ed data.
-
Vinson JA, Kharrat HA, Shuta D. Investigation of an amylase inhibitor on human glucose
absor ption after starch consumption. U npublished data supplied b y author. July 10, 2003.
Vinson JA, Shuta DM. In vivo effectiveness of a starch abso rption blocker in a double -
bli nd, pla cebocontrolled study with normal subjects. Unpubli sh ed data. Unive rsity of
Scranton. November, 20, 2001.
Layer P , Carlson GL, DiMagno EP. Parti ally purified white bea n amylase inhibitor reduces
sta rch digestion in vitro a nd inactiva tes intraduodenal amylase in humans.
gastroenter ology. 1985;88:1895-1902.
Layer P , Zinsmeister AR, DiMag no EP. Effects of decreasing intraluminal amylase activity
on starch digestion and postp randial gast rointestinal fun ction in humans. Gastroente rology.
1986;91:41-48.
Layer P , Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP. Effect of a pu ri fied
amylase inhibi tor on carboh ydrate tolerance in normal s ubjects and patients with diabetes
mellitus. Mayo Clin Proc. 1986;61:442-447.
Alcântara - Rua Yolanda Saad Abuzaid, 150, loja s 118/119. Telefone (21) 2601-1130
Ce ntro / Zé Garoto Rua Coronel Serrado, 1630, loja s 102/103. Telefone (21) 2605-1349
-
vendas@farmacam.com.br Facebook.com.br/farmacam
whatsapp (21) 98493-7033 Instagram.com.br/farmacam